Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin

Journal of Pharmaceutical Sciences

Volumn 92, Issue 2, 2003, Pages 297-310

  He, Ning ^a   Li, S Kevin ^a   Marjukka Suhonen, T ^a,b   Warner, Kevin S ^a   Higuchi, William I ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Azone; Enhancers; Hairless mouse skin; Partition; Permeation

Indexed keywords

2 PYRROLIDINONE; ALKANOL; AZACYCLOHEPTANONE DERIVATIVE; CYCLOHEPTANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; MOUSE; NONHUMAN; NUDE MOUSE; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 0037311323     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10269     Document Type: Article

References (39)

1. Allan G. 1995. Azone In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. Boca Raton, FL: CRC Press, Inc. pp 129-136.
2. Stoughton RB. 1982. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. Arch Dermatol 118:474-477.
3. Banerjee PS, Ritschel WA. 1989. Transdermal permeation of vasopressin. II. Influence of Azone on in vitro and in vivo permeation. Int J Pharm 49:199-204.
4. Okamoto H, Hashida M, Sezaki H. 1991. Effect of 1-alkyl- or 1-alkenylazacycloalkanone derivatives on the penetration of drugs with different lipophilicities through guinea pig skin. J Pharm Sci 80:39-45.
5. Hoogstraate AJ, Verhoef J, Brussee J, Ijzerman AP, Spies F, Bodde HE. 1991. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones. Int J Pharm 76:37-47.
6. Michniak BB, Player MR, Chapman JM, Sowell JW. 1993. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. I. Int J Pharm 91:85-93.
7. Michniak BB, Player MR, Fuhrman LC, Christensen CA, Chapman JM, Sowell JW. 1993. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. II. (Thio)amides. Int J Pharm 94:203-210.
8. Michniak BB, Player MR, Chapman JM, Sowell JW. 1994. Azone analogues as penetration enhancers: Effect of different vehicles on hydrocortisone acetate skin permeation and retention. J Control Release 32:147-154.
9. Brain KR, Walters KA. 1993. Molecular modeling of skin permeation enhancement by chemical agents. In: Walters KA, Hadgraft J, editors. Pharmaceutical skin penetration enhancement. New York: Marcel Dekker, Inc. pp 389-416.
10. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. 1995. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci 84:312-317.
11. Kim YH, Ghanem AH, Mahmoud H, Higuchi WI. 1992. Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin mechanism(s) of action. Int J Pharm 80:17-31.
12. Warner KS, Li SK, Higuchi WI. 2001. Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement. J Pharm Sci 90:1143-53.
13. Li SK, Ghanem AH, Yoneto K, Higuchi WI. 1997. Effects of 1 alkyl-2-pyrrolidones on the lipoidal pathway of human epidermal membrane: A comparison with hairless mouse skin. Pharm Res 14:S-303.
14. Kim YH, Ghanem AH, Higuchi WI. 1992. Model studies of epidermal permeability. Sem Dermatol 11:145-156.
15. Grubauer G, Feingold KR, Harris RM, Elias PM. 1989. Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res 30:89-96.
16. Sheu HM, Lee JY, Kuo KW, Tsai JC. 1998. Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: Characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography. J Dermatol 25:281-289.
17. Lampe MA, Williams ML, Elias PM. 1983. Human epidermal lipids: Characterization and modulations during differentiation. J Lipid Res 24:131-140.
18. Raykar PV, Fung MC, Anderson BD. 1988. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm Res 5:140-150.
19. Kligman AM, Christophers E. 1963. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:702-705.
20. Yoneto K, Li SK, Higuchi WI, Shimabayashi S. 1998. Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci 87:209-214.
21. Ghanem AH, Mahmoud H, Higuchi WI, Rohr UD, Borsadia S, Liu P, Fox JL, Good WR. 1987. The effects of ethanol on the transport of estradiol and other permeants in hairless mouse skin. II. A new quantitative approach. J Control Release 6:75-83.
22. Ghanem AH, Mahmound H, Higuchi WI, Liu P, Good WR. 1992. The effects of ethanol on the transport of lipophilic and polar permeants across hairless mouse skin: Methods/validation of a novel approach. Int J Pharm 78:137-156.
23. Byrn S. 1982. Solid-state chemistry of drugs. New York: Academic Press. pp 116-118.
24. Roberts MS, Walters KA. 1998. The relationship between structure and barrier function of skin. In: Roberts MS, Walters KA, editors. Dermal absorption and toxicity assessment. New York: Marcel Dekker, Inc. pp 12-15.
25. Abrams K, Harvell JD, Shriner D, Wertz P, Maibach H, Maibach HI, Rehfeld SJ. 1993. Effect of organic solvents on in vitro human skin water barrier function. J Invest Dermatol 101:609-613.
26. Smith SW. 1992. Lauric acid solution thermodynamics and effects on stratum corneum permeability. PhD. Thesis, University of Utah, Salt Lake City, UT.
27. Nicolaides N, Fu HC, Rice GR. 1968. The skin surface lipids of man compared with those of eighteen species of animals. J Invest Dermatol 51:83-89.
28. Nicolaides N. 1974. Skin lipids: Their biochemical uniqueness. Science 186:19-26.
29. Grubauer G, Elias PM, Feingold KR. 1989. Transepidermal water loss: The signal for recovery of barrier structure and function. J Lipid Res 30:323-333.
30. Tanford C. 1980. The hydrophobic effect: Formation of micelles and biological membranes, 2nd ed. New York: John Wiley & Sons.
31. Hiemenz PC, Rajagopalan R. 1997. Principles of colloid and surface chemistry, 3rd ed. New York: Marcel Dekker, Inc.
32. Johnson ME, Blankschtein D, Langer R. 1997. Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism. J Pharm Sci 86: 1162-1172.
33. Mitragotri S. 2001. Effect of bilayer disruption on transdermal transport of low-molecular weight hydrophobic solutes. Pharm Res 18:1018-1023.
34. Yoneto K, Li SK, Higuchi WI, Jiskoot W, Herron JN. 1996. Fluorescent probe studies of the interactions of 1-alkyl-2-pyrrolidones with stratum corneum lipid liposomes. J Pharm Sci 85:511-517.
35. Xiang TX, Chen X, Anderson BD. 1992. Transport methods for probing the barrier domain of lipid bilayer membranes. Biophys J 63:78-88.
36. Xiang TX, Anderson BD. 1994. Substituent contributions to the transport of substituted p-toluic acids across lipid bilayer membranes. J Pharm Sci 83:1511-1518.
37. Xiang TX, Anderson BD. 1994. Molecular distributions in interphases: Statistical mechanical theory combined with molecular dynamics simulation of a model lipid bilayer. Biophys J 66:561-573.
38. Kim YH, Higuchi WI, Herron JN, Abraham W. 1993. Fluorescence anisotropy studies on the interaction of the short chain n-alkanols with stratum corneum lipid liposomes (SCLL) and distearoylphosphatidylcholine (DSPC)/distearoylphosphatidic acid (DSPA) liposomes. Biochim Biophys Acta 1148:139-151.
39. Yoneto K, Li SK, Ghanem AH, Crommelin DJ, Higuchi WI. 1995. A mechanistic study of the effects of the 1-alkyl-2-pyrrolidones on bilayer permeability of stratum corneum lipid liposomes: A comparison with hairless mouse skin studies. J Pharm Sci 84:853-861.